Related News

Significant Disparities in Care for Pediatric Retinoblastoma

Oct 7, 2015

Extraocular disease higher among Hispanic children, counties with low socioeconomic status

High-Dose Hypofractionated RT Palliative in Head, Neck Cancer

Oct 7, 2015

Meaningful palliative effect for 63 percent of patients, lasting for median of 4.6 months

FDA Approves Keytruda for Advanced NSCLC

Oct 5, 2015

Approved for use with PD-L1 IHC 22C3 pharmDx test

Frequently Asked Questions